The bill introduces new regulations for stem cell therapy in Florida by creating sections 458.3245 and 459.0127 of the Florida Statutes. It emphasizes the ethical sourcing of stem cells, explicitly prohibiting the use of stem cells derived from aborted fetuses. Physicians are permitted to perform non-FDA approved stem cell therapies under specific conditions, particularly in orthopedics, wound care, and pain management. The bill sets forth strict requirements for the sourcing, manufacturing, and storage of stem cells, mandating that they originate from certified facilities that comply with current good manufacturing practices.

Furthermore, the bill mandates that physicians provide clear notices in advertisements regarding the unapproved status of the therapies and obtain informed consent from patients prior to treatment. The consent form must detail the treatment's nature, potential risks, and a recommendation for patients to consult with their primary care provider. Violations of these regulations could result in disciplinary actions and criminal penalties for physicians. The Board of Medicine is authorized to adopt necessary rules to ensure the safe and ethical conduct of stem cell therapies in Florida, with the act set to take effect on July 1, 2025.